- Home
- KUKE vs FBIOP Comparison
KUKE vs FBIOP Comparison
Compare KUKE & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KUKE
- FBIOP
- Stock Information
- Founded
- KUKE 2002
- FBIOP N/A
- Country
- KUKE China
- FBIOP United States
- Employees
- KUKE N/A
- FBIOP 101
- Industry
- KUKE Other Consumer Services
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- KUKE Real Estate
- FBIOP Health Care
- Exchange
- KUKE Nasdaq
- FBIOP Nasdaq
- Market Cap
- KUKE N/A
- FBIOP N/A
- IPO Year
- KUKE 2021
- FBIOP N/A
- Fundamental
- Price
- KUKE $4.27
- FBIOP $6.61
- Analyst Decision
- KUKE
- FBIOP
- Analyst Count
- KUKE 0
- FBIOP 0
- Target Price
- KUKE N/A
- FBIOP N/A
- AVG Volume (30 Days)
- KUKE 11.7K
- FBIOP N/A
- Earning Date
- KUKE 05-27-2025
- FBIOP N/A
- Dividend Yield
- KUKE N/A
- FBIOP N/A
- EPS Growth
- KUKE N/A
- FBIOP N/A
- EPS
- KUKE N/A
- FBIOP N/A
- Revenue
- KUKE $14,784,158.00
- FBIOP N/A
- Revenue This Year
- KUKE N/A
- FBIOP N/A
- Revenue Next Year
- KUKE N/A
- FBIOP N/A
- P/E Ratio
- KUKE N/A
- FBIOP N/A
- Revenue Growth
- KUKE 10.48
- FBIOP N/A
- 52 Week Low
- KUKE $0.15
- FBIOP N/A
- 52 Week High
- KUKE $4.58
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- KUKE 62.59
- FBIOP 58.26
- Support Level
- KUKE $3.80
- FBIOP $6.15
- Resistance Level
- KUKE $4.42
- FBIOP $6.50
- Average True Range (ATR)
- KUKE 0.27
- FBIOP 0.31
- MACD
- KUKE -0.09
- FBIOP -0.02
- Stochastic Oscillator
- KUKE 57.32
- FBIOP 75.37
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.